AngioDynamics Q4 sales $87M (+13% YoY), GAAP EPS -$0.16; FY23 rev guide $342-348M

ANGIODYNAMICS INC

2022-FY EPS reported -$0.68 revenue$316,219,000

Q4 net sales $87.0M (+13.2% YoY); Med Tech sales up 40% to $22.6M.
GAAP loss per share $0.16; adjusted EPS $0.01; full-year GAAP loss $0.68.
Full-year net sales $316.2M (+8.7% YoY); gross margin declined 150 bps to 52.4%.
FY2023 guidance: net sales $342-348M, gross margin 52.5-54.5%, adjusted EPS $0.01-$0.06.
Cash $28.8M at May 31; $25M drawn on revolver; operating cash flow $8.6M in Q4.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.